Testosterone Lawsuits Move Forward, as Bernstein Liebhard LLP Notes Push for Stronger Heart Attack W

The Firm is investigating testosterone treatment lawsuits on behalf of men who suffered heart attacks, strokes, deep vein thrombosis, pulmonary embolism, or other serious cardiovascular problems, allegedly due to AndroGel and other low testosterone therapies. New York, NY (PRWEB) February 26, 2014 As testosterone lawsuits (http://www.testosteronelawsuitcenter.com/ ) involving AndroGel continue to mount, Bernstein Liebhard LLP notes that a leading consumer advocacy group is pushing federal regulators to add new safety warnings to the labeling for this class of medication. According to a C
Contributor
About
PRWeb, a leader in online news and press release distribution, has been used by attorneys, law firms and more than 40,000 organizations